Natalia Ashtamker

Statistics

Publications

Citations

H-Index

Active since

2016

Affiliations

Teva Pharmaceuticals (Israel)(Current)

Teva Pharmaceuticals (Czechia)

Wayne State University

Natalia Ashtamker is an author at Teva Pharmaceuticals (Israel) specializing in dose escalation, relapsing-remitting multiple sclerosis treatment, and pharmacotherapy.

Publications per year

2016–2017

Publications

Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing–remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study

Omar Khan, Krzysztof Selmaj, Natalia Ashtamker et al. · Multiple Sclerosis Journal · 2016 · 36 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +12

The Relationship Between Brain MR Spectroscopy and Disability in Multiple Sclerosis: 20‐Year Data from the U.S. Glatiramer Acetate Extension Study

Omar Khan, Navid Seraji‐Bozorgzad, Fen Bao et al. · Journal of Neuroimaging · 2016 · 28 citations · Full text

Medicine, Neurology, Neuroscience +16

Time course of glatiramer acetate efficacy in patients with RRMS in the GALA study

Mat D. Davis, Natalia Ashtamker, Joshua R. Steinerman et al. · Neurology Neuroimmunology & Neuroinflammation · 2017 · 12 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

1–3 of 3